What Rosacea Actually Is

Rosacea is a chronic, relapsing inflammatory skin disorder of the central face — forehead, cheeks, nose, and chin — characterised by vascular dysfunction, neurogenic inflammation, and dysbiosis of the skin microbiome (particularly elevated Demodex density and altered bacterial composition).

It affects an estimated 5–10% of the global population and is frequently misdiagnosed as acne, eczema, or simple sensitivity. The distinction matters because most conventional acne treatments — particularly harsh AHAs, strong retinoids, and benzoyl peroxide — can severely worsen rosacea.

The Four Subtypes

SubtypePresentationPrimary Features
ETR (Erythematotelangiectatic)Persistent central redness, flushing, visible blood vesselsVascular — telangiectasia, diffuse redness, burning/stinging
PPR (Papulopustular)Acne-like papules and pustules with background rednessMost commonly misdiagnosed as acne; no comedones
PhymatousSkin thickening, irregular textureRhinophyma (nose enlargement); more common in males
OcularEye irritation, redness, wateringOften accompanies other subtypes; requires ophthalmology input

Identifying Personal Triggers

Rosacea has no universal trigger set — triggers are highly individual. The most common:

  • UV radiation (most consistent universal trigger)
  • Heat: hot showers, exercise, hot drinks, saunas
  • Emotional stress (neurogenic flushing via neuropeptide release)
  • Alcohol — particularly red wine, spirits (histamine, prostaglandin release)
  • Spicy foods — capsaicin activates TRPV1 receptors → neurogenic flushing
  • Skin products containing fragrance, alcohol denat., eucalyptus, menthol

The trigger diary: Track meals, environment, products, and stress levels alongside flare incidents for 4–6 weeks. Patterns emerge that are specific to your rosacea — not generalisable to everyone's.

Evidence-Based Topical Approach

  • Azelaic acid 15–20%: Anti-inflammatory, reduces papulopustular lesions, mildly reduces redness — first-line topical
  • Ivermectin 1% (Rx): Targets Demodex overgrowth and has anti-inflammatory properties — strong RCT evidence for PPR subtype
  • Niacinamide 5%: Anti-inflammatory, vasoconstrictive, barrier-supportive — well-tolerated in rosacea
  • Metronidazole 0.75–1% (Rx): Antimicrobial and anti-inflammatory; standard Rx first-line for PPR
  • Brimonidine tartrate 0.5% (Rx): Alpha-adrenergic agonist — vasoconstricts for up to 12 hours; for ETR subtype redness

For the microbiome dysfunction underlying rosacea, see Skin Microbiome. For the gut-rosacea link, see Gut-Skin Axis.